Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · NextPlat Corp (NXPL)

NextPlat Completes $1.5 Million Acquisition of Profitable Pensacola-Area Pharmacy

Neutral Impact 2 of 5 m&a Written later

NextPlat Corp said it completed its previously announced acquisition of an independent pharmacy near Pensacola, Florida, for total cash consideration of $1,485,439. The pharmacy generated approximately $5.6 million in sales for the year ended December 31, 2025, and the company said it was profitable. The filing does not report the impact on NextPlat's consolidated results, so shareholders can see the deal size but not its effect on company earnings.

Key points

  • Total cash consideration for the pharmacy and its inventory was $1,485,439.
  • The pharmacy generated approximately $5.6 million in sales for the year ended December 31, 2025.
  • The pharmacy will be integrated into the PharmcoRx segment, which now operates five pharmacies in Florida.
  • The deal was announced in a press release dated October 6, 2026, filed as Exhibit 99.1.

The filing

CompanyNextPlat Corp (NXPL)
Form8-K, current report
Filed with the SECOct 6, 2026, 4:17 PM ET
Accession number0001437749-26-032200

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:28 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 06, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.